Why Do You Need to Increase Your Mounjaro Dose?

The myth: a higher dose just means a stronger medicine you take when things stop working

This is the misunderstanding our prescribers hear most often. People assume that moving up a dose is a rescue move, something you do when Mounjaro has somehow failed. In reality, the titration schedule built into Mounjaro's licence is not reactive. It is the plan from the start. Eli Lilly and regulators designed the 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg progression as a single structured course, not a series of independent options. Starting low is the medicine working correctly, not working inadequately.

The NHS's patient information for tirzepatide explains this clearly: the initial dose is chosen to let your system adjust to the way the medicine affects gastric emptying and gut-hormone signalling, not to begin meaningful weight loss. Anyone who expects significant results at 2.5mg is measuring against the wrong benchmark. The typical weight loss at 2.5mg is modest for this reason. That is expected, and fine.

Understanding this reframes the whole experience. An increase isn't a correction; it's the next scheduled chapter.

Why the therapeutic effect builds at higher doses

Tirzepatide works by activating both GIP and GLP-1 receptors, two gut-hormone pathways involved in appetite regulation, gastric emptying and blood-sugar control. At lower doses, receptor engagement is partial. As the dose increases, the degree of receptor activation rises, and with it the appetite-suppressing effect. This is why the SURMOUNT-1 trial, summarised by the NHS, saw average body-weight reductions of around 20–21% over 72 weeks at the 15mg dose, figures that are substantially larger than those seen at lower maintenance doses in the same programme.

There is also a pharmacological argument for graduated increases beyond just tolerability. Some people notice that appetite suppression feels less pronounced after several weeks at one dose level. This is not failure; it is a normal biological accommodation. Moving to the next step restores the signal strength. Your prescriber looks at your progress (weight trend, side-effect pattern, how you're feeling) before deciding whether an increase is appropriate. At nume, that review happens before every repeat, with a real clinician reading your answers, not an automated system. If you're wondering whether you actually have to increase your Mounjaro dose at all, the answer depends on your individual progress and what your prescriber finds at review. You can read more about when a dose increase is typically considered and what prompts one.

Not everyone needs the maximum, and that's backed by the evidence

One thing that gets lost in conversations about titration is the nuance. The licensed schedule runs to 15mg, but NICE's appraisal of tirzepatide (TA1026) notes that continuing treatment is reviewed if weight loss is less than 5% after six months at the highest tolerated dose. "Highest tolerated" is the operative phrase. Some people reach excellent results at 7.5mg or 10mg and have no clinical reason to go further. Others tolerate and benefit from continuing to 12.5mg or 15mg.

The right dose is not the highest dose. It is the dose where meaningful progress and acceptable tolerability meet, a balance your prescriber tracks over time. If you're unsure whether your current dose is doing what it should, the question of whether an increase is needed is one worth raising properly, not guessing at. Private treatment costs are also worth understanding in this context; the cost of Mounjaro varies by dose and provider, which is worth factoring into your planning. [Source: NICE Technology Appraisal TA1026]

What this means in practice, and who decides

You may feel some frustration right now, progress seems slower than you expected, or you're not sure whether to push for a higher dose or stay put. That's a genuinely common feeling, and it's worth saying plainly: the titration timeline can feel slow when you're in the middle of it. Four weeks at each level is the minimum, and patience at the early doses pays off in better tolerability later.

In practice, a dose increase requires clinical sign-off. At nume, our GPhC-registered Independent Prescribers review the evidence you provide (weight readings, how you've been tolerating the current dose, any side effects) before approving a change. No increase goes through without that assessment. This protects you: moving up too quickly is one of the most common reasons people experience more pronounced nausea or other GI effects than they need to. A prescriber can also spot when staying at a lower dose is actually the better call. For a full picture of the medicine and how it fits the treatment pathway, the Mounjaro overview sets out what to expect from the start. Questions our team fields regularly are also covered in the FAQs.